{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:46:37Z","timestamp":1785818797975,"version":"3.56.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100022999","name":"Megmilk Snow Brand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022999","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Although the gut microbiome is involved in the pathogenesis of knee osteoarthritis (OA), the effects of dietary supplementation remain controversial. Probiotics are a promising option for lifestyle management of inflammatory diseases. This study aimed to investigate the effects of dietary supplementation with probiotics on subjective symptoms and the gut microbiome in adults with knee pre-OA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      For the\n                      <jats:italic>in vitro<\/jats:italic>\n                      laboratory selection of probiotic strains, 110 strains of lactic acid bacteria and bifidobacteria were serially examined for expression profiles of OA-related genes in interleukin-1\u03b2\u2013stimulated SW982 cells. The clinical trial was a double-blind, placebo-controlled, randomized clinical trial of Japanese adults with knee pre-OA based on Kellgren\u2013Lawrence grade 0 or 1 and subjective symptoms. Probiotics or a placebo were administered during a 12-week intervention from January to April 2024. The primary outcomes were pain, stiffness, and discomfort in both knees, assessed using the visual analog scale (VAS). Secondary outcomes included subjective assessments, gut microbiome, blood biochemistry, and safety profiles, including adverse events.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Ligilactobacillus salivarius<\/jats:italic>\n                      SBT2687 (LS2687) was identified in the analysis of gene expression profiles of SW982 cells. For the clinical trial, 108 participants (median age 52.0 years [IQR 47.0\u201357.0], 65.7% female) were included in the study. A greater reduction was observed in VAS scores for all symptoms in the LS2687 group than in the placebo group at 12 weeks (pain: \u22122.9 \u00b1 6.1 vs. \u22121.7 \u00b1 4.8,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.048; stiffness: \u22123.6 \u00b1 7.1 vs. \u22121.3 \u00b1 5.1,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.014; discomfort: \u22123.8 \u00b1 7.5 vs. \u22121.7 \u00b1 5.3,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.016), although the between-group improvements did not survive baseline adjustment (ANCOVA\n                      <jats:italic>P<\/jats:italic>\n                      = 0.14\u20130.24). The species-level relative abundance of\n                      <jats:italic>Lactobacillus salivarius<\/jats:italic>\n                      increased in the LS2687 group (from 3.63% to 35.49%;\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001 and 0.005 in within- and between-group comparisons, respectively). No adverse events were associated with this intervention throughout the study.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>LS2687 supplementation was well-tolerated and provided new insights into the probiotic management of knee pre-OA. The gut-knee axis should be considered in the management of symptoms with knee pre-OA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Trial Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/center6.umin.ac.jp\/cgi-open-bin\/ctr\/ctr_view.cgi?recptno=R000059864,<\/jats:ext-link>\n                      identifier [R000059864].\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2026.1863405","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:27:14Z","timestamp":1785817634000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Laboratory-selected, probiotic Ligilactobacillus salivarius SBT2687 supplementation is associated with subjective knee symptoms and the gut microbiome in adults with pre-osteoarthritis: a randomized controlled trial in Japanese"],"prefix":"10.3389","volume":"13","author":[{"given":"Erina","family":"Ushizawa","sequence":"first","affiliation":[{"name":"Milk Science Research Institute, Megmilk Snow Brand Co., Ltd.","place":["Kawagoe, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiko","family":"Yasueda","sequence":"additional","affiliation":[{"name":"Milk Science Research Institute, Megmilk Snow Brand Co., Ltd.","place":["Kawagoe, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayatake","family":"Nakano","sequence":"additional","affiliation":[{"name":"Milk Science Research Institute, Megmilk Snow Brand Co., Ltd.","place":["Kawagoe, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Sugino","sequence":"additional","affiliation":[{"name":"Soiken Inc.","place":["Toyonaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Fukuda Clinic","place":["Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi M.","family":"Ueno","sequence":"additional","affiliation":[{"name":"Milk Science Research Institute, Megmilk Snow Brand Co., Ltd.","place":["Kawagoe, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"152652","DOI":"10.1016\/j.semarthrit.2025.152652","article-title":"Transformative approaches for effective clinical trials to reduce the disease burden of osteoarthritis.","volume":"71","author":"Chu","year":"2025","journal-title":"Semin Arthritis Rheum."},{"key":"B2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1177\/1947603515586048","article-title":"Pre-osteoarthritis: definition and diagnosis of an elusive clinical entity.","volume":"6","author":"Ryd","year":"2015","journal-title":"Cartilage."},{"key":"B3","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.joca.2025.12.016","article-title":"Reframing early-stage symptomatic knee osteoarthritis (EsSKOA): a strategic lens for trial design.","volume":"34","author":"Mahmoudian","year":"2026","journal-title":"Osteoarthritis Cartilage."},{"key":"B4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/ar3845","article-title":"Early diagnosis to enable early treatment of pre-osteoarthritis.","volume":"14","author":"Chu","year":"2012","journal-title":"Arthritis Res Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1136\/bjsports-2016-097333","article-title":"Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis.","volume":"52","author":"Liu","year":"2018","journal-title":"Br J Sports Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e002167","DOI":"10.1136\/rmdopen-2021-002167","article-title":"Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations.","volume":"8","author":"Gwinnutt","year":"2022","journal-title":"RMD Open"},{"key":"B7","doi-asserted-by":"publisher","first-page":"CD005614","DOI":"10.1002\/14651858.CD005614.pub2","article-title":"Chondroitin for osteoarthritis.","volume":"1","author":"Singh","year":"2015","journal-title":"Cochrane Database Syst Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11926-023-01108-7","article-title":"The potential role of probiotics in the management of osteoarthritis pain: current status and future prospects.","volume":"25","author":"Rahman","year":"2023","journal-title":"Curr Rheumatol Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11926-024-01166-5","article-title":"Unveiling the potential of probiotics in osteoarthritis management.","volume":"27","author":"Karim","year":"2024","journal-title":"Curr Rheumatol Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.it.2025.01.006","article-title":"New thoughts on the gut-immune axis of arthritis.","volume":"46","author":"Thiran","year":"2025","journal-title":"Trends Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"eadt0548","DOI":"10.1126\/science.adt0548","article-title":"Osteoarthritis treatment via the GLP-1-mediated gut-joint axis targets intestinal FXR signaling.","volume":"388","author":"Yang","year":"2025","journal-title":"Science."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2489069","DOI":"10.1080\/19490976.2025.2489069","article-title":"Bacterial extracellular vesicles in osteoarthritis: a new bridge of the gut-joint axis.","volume":"17","author":"Niu","year":"2025","journal-title":"Gut Microbes."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1150572","DOI":"10.3389\/fimmu.2023.1150572","article-title":"\u201cCross-talk\u201d between gut microbiome dysbiosis and osteoarthritis progression: a systematic review.","volume":"14","author":"Liu","year":"2023","journal-title":"Front Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"9208","DOI":"10.3390\/ijms22179208","article-title":"Cytokines and chemokines involved in osteoarthritis pathogenesis.","volume":"22","author":"Molnar","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.joca.2016.12.029","article-title":"Altered gait mechanics and elevated serum pro-inflammatory cytokines in asymptomatic patients with MRI evidence of knee cartilage loss.","volume":"25","author":"Edd","year":"2017","journal-title":"Osteoarthritis Cartilage."},{"key":"B16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fmed.2018.00124","article-title":"Strain-specificity and disease-specificity of probiotic efficacy: a systematic review and meta-analysis.","volume":"5","author":"McFarland","year":"2018","journal-title":"Front Med (Lausanne)."},{"key":"B17","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"Expert consensus document. The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic.","volume":"11","author":"Hill","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3920\/BM2016.0207","article-title":"The effect of probiotic Lactobacillus casei Shirota on knee osteoarthritis: a randomised double-blind, placebo-controlled clinical trial.","volume":"8","author":"Lei","year":"2017","journal-title":"Benef Microbes."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e03757","DOI":"10.1016\/j.heliyon.2020.e03757","article-title":"Oral intake of Streptococcus thermophil us improves knee osteoarthritis degeneration: a randomized, double-blind, placebo-controlled clinical study.","volume":"6","author":"Lyu","year":"2020","journal-title":"Heliyon."},{"key":"B20","first-page":"1524","article-title":"An outcome measure for Japanese people with knee osteoarthritis.","volume":"32","author":"Akai","year":"2005","journal-title":"J Rheumatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1007\/s00776-012-0274-0","article-title":"Validity and reliability of the Japanese orthopaedic association score for osteoarthritic knees.","volume":"17","author":"Okuda","year":"2012","journal-title":"J Orthop Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads.","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnet J."},{"key":"B23","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","article-title":"Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2.","volume":"37","author":"Bolyen","year":"2019","journal-title":"Nat Biotechnol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","article-title":"DADA2: high-resolution sample inference from Illumina amplicon data.","volume":"13","author":"Callahan","year":"2016","journal-title":"Nat Methods."},{"key":"B25","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","article-title":"The SILVA ribosomal RNA gene database project: improved data processing and web-based tools.","volume":"41","author":"Quast","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics.","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.joca.2024.07.005","article-title":"The impact of an illness perception conversation on open-label placebo response in knee osteoarthritis: A randomised controlled trial.","volume":"32","author":"Ginnerup-Nielsen","year":"2024","journal-title":"Osteoarthritis Cartilage."},{"key":"B28","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1507\/endocrj.EJ23-0593","article-title":"Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan.","volume":"71","author":"Ogawa","year":"2024","journal-title":"Endocr J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4314\/ajtcam.v10i1.7","article-title":"Active compound of Zingiber cassumunar Roxb. down-regulates the expression of genes involved in joint erosion in a human synovial fibroblast cell line.","volume":"10","author":"Chaiwongsa","year":"2012","journal-title":"Afr J Tradit Complement Altern Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"561459","DOI":"10.1155\/2014\/561459","article-title":"The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis.","volume":"2014","author":"Wojdasiewicz","year":"2014","journal-title":"Mediators Inflamm."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e15588","DOI":"10.1016\/j.heliyon.2023.e15588","article-title":"Anti-inflammatory effect of glycyrrhetinic acid in IL-1\u03b2-induced SW982 cells and adjuvant-induced arthritis.","volume":"9","author":"Song","year":"2023","journal-title":"Heliyon."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1134\/S0006297925600863","article-title":"Leptin potentiates the inflammatory effect of interleukin-1 beta on synoviocytes. potential preventive role of DHA and EPA in osteoarthritis cell model.","volume":"90","author":"Wayupat","year":"2025","journal-title":"Biochemistry (Mosc)."},{"key":"B33","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s13075-017-1454-2","article-title":"New insights on the MMP-13 regulatory network in the pathogenesis of early osteoarthritis.","volume":"19","author":"Li","year":"2017","journal-title":"Arthritis Res Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"5706359","DOI":"10.1155\/2016\/5706359","article-title":"Nerve growth factor regulation by TNF-\u03b1 and IL-1\u03b2 in synovial macrophages and fibroblasts in osteoarthritic mice.","volume":"2016","author":"Takano","year":"2016","journal-title":"J Immunol Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e9510","DOI":"10.2903\/j.efsa.2025.9510","article-title":"Update of the list of qualified presumption of safety (QPS) recommended microbiological agents intentionally added to food or feed as notified to EFSA 22: suitability of taxonomic units notified to EFSA until March 2025.","volume":"23","author":"Allende","year":"2025","journal-title":"EFSA J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e063026","DOI":"10.1136\/bmjopen-2022-063026","article-title":"Minimal important change and difference for knee osteoarthritis outcome measurement tools after non-surgical interventions: a systematic review.","volume":"13","author":"Silva","year":"2023","journal-title":"BMJ Open."},{"key":"B37","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3390\/brainsci15070761","article-title":"Effects of probiotic supplementation on depressive symptoms, sleep quality, and modulation of gut microbiota and inflammatory biomarkers: a randomized controlled trial.","volume":"15","author":"Ahmad","year":"2025","journal-title":"Brain Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"107445","DOI":"10.1016\/j.phrs.2024.107445","article-title":"Baseline gut microbiome as a predictive biomarker of response to probiotic adjuvant treatment in gout management.","volume":"209","author":"Zhao","year":"2024","journal-title":"Pharmacol Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1017\/S0007114524002824","article-title":"Probiotics\u2019 supplementation alleviates disease severity and improves postural balance by repairing intestinal leak in patients suffering from osteoarthritis: a double-blinded clinical trial.","volume":"132","author":"Karim","year":"2024","journal-title":"Br J Nutr."},{"key":"B40","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.joca.2020.10.004","article-title":"Visual analogue scale has higher assay sensitivity than WOMAC pain in detecting between-group differences in treatment effects: a meta-epidemiological study.","volume":"29","author":"da Costa","year":"2021","journal-title":"Osteoarthritis Cartilage."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1759720X221131604","DOI":"10.1177\/1759720X221131604","article-title":"Early osteoarthritis questionnaire (EOAQ): a tool to assess knee osteoarthritis at initial stage.","volume":"15","author":"Migliore","year":"2023","journal-title":"Ther Adv Musculoskelet Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1744478","DOI":"10.3389\/fmed.2025.1744478","article-title":"Risk factors associated with knee osteoarthritis severity and their correlation with Kellgren-Lawrence grade.","volume":"12","author":"Chen","year":"2026","journal-title":"Front Med (Lausanne)."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1863405\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:27:15Z","timestamp":1785817635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1863405\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":42,"alternative-id":["10.3389\/fnut.2026.1863405"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1863405","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"article-number":"1863405"}}